DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



QuantiFERON Change During Anti-tuberculosis Medication

Information source: Armed Forces Capital Hospital, Republic of Korea
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Tuberculosis; Interferon-gamma Release Assay

Phase: N/A

Status: Completed

Sponsored by: Armed Forces Capital Hospital, Republic of Korea

Summary

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Clinical Details

Official title: The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment

Study design: Observational Model: Cohort, Time Perspective: Prospective

Detailed description: Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- All subjects with active tuberculosis

Exclusion Criteria:

- Subjects who cannot complete study

- Subjects who have taken anti-tuberculosis medication for more than a month before

visit of our hospital

Locations and Contacts

Armed Forces Capital Hospital, Seongnam, Gyeonggi-do 463-040, Korea, Republic of
Additional Information

Starting date: May 2008
Last updated: June 11, 2010

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017